A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis - Study design and rationale of HM-TRIA-201 study
While further clinical trials with long-term follow-up periods are still required, ALC appears to be a safe, well-tolerated, and effective potential treatment option for DPN
Because it is broken down into amino acids and small peptides during digestion, its impact on breast milk is likely minimal
That could be especially dangerous for those with diabetes who may not be able to feel a serious problem developing on the foot
Below, we explain what could be behind your aches and pains on Ozempic and what you can do about it